2-(4-((2,2-Dimethyl-1,3-dioxolan-4-yl)methoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

Catalog No. :
ACNCZP638
CAS No. :
1628018-52-9
Molecular Formula :
C18H27BO5
Molecular Weight :
334.22

IUPAC Name:2-(4-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane

2-(4-((2,2-Dimethyl-1,3-dioxolan-4-yl)methoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$972.00Login to see priceInquiryInquiry
5g98%$1945.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-(4-((2,2-Dimethyl-1,3-dioxolan-4-yl)methoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
IUPAC Name2-(4-((2,2-dimethyl-1,3-dioxolan-4-yl)methoxy)phenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane
MDL No.MFCD31716200
Molecular FormulaC18H27BO5
Molecular Weight334.22
SMILESCC1(C)C(C)(C)OB(C2=CC=C(OCC3OC(C)(C)OC3)C=C2)O1
InChI KeyRYKXQTNVHBSLFW-UHFFFAOYSA-N
Synonym2-[4-(2,2-Dimethyl-[1,3]dioxolan-4-ylmethoxy)-phenyl]-4,4,5,5-tetramethyl-[1,3,2]dioxaborolane;1,3,2-Dioxaborolane, 2-[4-[(2,2-dimethyl-1,3-dioxolan-4-yl)methoxy]phenyl]-4,4,5,5-tetramethyl-
CAS No.1628018-52-9

Synthetic Route by SureRoute

1. ACNCZP638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACFDJO835 route compound structure diagram
    ACFDJO835269409-70-3 In Stock
  2. Plus
  3. ACVBQR534 route compound structure diagram
    ACVBQR53436236-76-7 In Stock
  4. Then
  5. ACNCZP638 route product structure diagram
    ACNCZP6381628018-52-9
Inquiry

2. ACNCZP638 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTOBU801 route compound structure diagram
    ACTOBU80173183-34-3 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNCZP638 route product structure diagram
    ACNCZP6381628018-52-9
Inquiry

Comments (0)